In this episode of the Marketbull podcast, host Ben Kosterich speaks with Ward Detwiler, Chief Business Officer, and Susan Harvey, Medical Affairs Advisor of Imagion Biosystems listed on the ASX: IBX. They discuss the company's MagSense technology, a new functional imaging agent that holds the promise of being more sensitive and safer for diagnosing various cancers. Ward and Susan share their extensive backgrounds in the medical technology field and the importance of early detection and accurate diagnosis in cancer treatment. The conversation dives into the revolutionary potential of MagSense and the promising future of AI in medical imaging.
Imagion Biosystems website - https://imagionbiosystems.com
Sponsors:
True Resources is a top tier recruitment agency. Sourcing and placing the best people across the mining and resource sector: https://trueresources.com.au/
CPS Capital is a boutique Corporate Finance and Stockbroking firm based in Perth and Melbourne providing specialist advice to retail, sophisticated and institutional investors within Australia and around the globe: https://www.cpscapital.com.au/
Gyro Drilling delivers cost effective, quality drilling services to clients throughout Western Australia and across the country: https://gyroaustralia.com.au/
Dorrington Plumbing, Gas & Electrical offers a complete range of plumbing, gas & electrical services to residential, and commercial businesses and property managers:
https://dorringtonplumbing.com.au
Chapters:
00:00 Introduction
00:11 Meet the Guests
00:46 Ward's Journey in Medical Technology
02:32 Susan's Personal and Professional Background
05:04 Challenges in Current Cancer Diagnosis
08:35 Imagion Biosystems: Mission and Technology
10:39 What is MagSense?
13:01 Future Potential and Applications
26:46 Clinical Development and Regulatory Pathway
34:39 Collaborations and Partnerships
44:52 Closing Remarks and Contact Information
Follow the Market bull:
Please note, that the topics and stocks discussed in this podcast are not financial or investment advice.